Sergio Ermotti – UBS Successor – May Cut Investment

Sergio Ermotti, the heir apparent for UBS’s leadership, will likely be tasked with slashing the investment aspect of the company in order to refocus on wealth management.


Sergio Ermotti Second In Line to Oswald Grubel

After the $2.3 billion rogue trading scandal, plans to accelerate CEO Oswald Grubel’s departures accelerated in order to speed up restructuring and senior management changes. In 2009, Grubel was brought out of retirement to run UBS following huge losses on subprime assets that lead to its bailout by the Swiss government. Sixty-seven year old Gruebel had run Credit Suisse and was retired when UBS sought him to clean out UBS from the fallout of the subprime mortgage debacle.

Sergio Ermotti Background

Sergio Ermotti is the former deputy executive director of Unicredit. Before that the Italian-speaking Swiss was with Merrill Lynch for nearly two decades.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!